Apyx Medical Corp Stock Fundamentals
| BOV Stock | 1.35 0.04 3.05% |
Apyx Medical Corp fundamentals help investors to digest information that contributes to Apyx Medical's financial success or failures. It also enables traders to predict the movement of Apyx Stock. The fundamental analysis module provides a way to measure Apyx Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apyx Medical stock.
Apyx |
Apyx Medical Corp Company Revenue Analysis
Apyx Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Apyx Medical Revenue | 48.52 M |
Most of Apyx Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apyx Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Apyx Medical Corp reported 48.52 M of revenue. This is much higher than that of the sector and significantly higher than that of the Revenue industry. The revenue for all Germany stocks is notably lower than that of the firm.
Apyx Medical Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apyx Medical's current stock value. Our valuation model uses many indicators to compare Apyx Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apyx Medical competition to find correlations between indicators driving Apyx Medical's intrinsic value. More Info.Apyx Medical Corp is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Apyx Medical Corp is about 33,308,845 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Apyx Medical's earnings, one of the primary drivers of an investment's value.Apyx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apyx Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apyx Medical could also be used in its relative valuation, which is a method of valuing Apyx Medical by comparing valuation metrics of similar companies.Apyx Medical is currently under evaluation in revenue category among its peers.
Apyx Fundamentals
| Current Valuation | 51.28 M | |||
| Price To Book | 1.54 X | |||
| Price To Sales | 1.32 X | |||
| Revenue | 48.52 M | |||
| EBITDA | (13.91 M) | |||
| Net Income | (15.17 M) | |||
| Cash Flow From Operations | (10.45 M) | |||
| Market Capitalization | 405.37 M | |||
| Total Asset | 68.72 M | |||
| Net Asset | 68.72 M |
About Apyx Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apyx Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apyx Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.